Free-cash-flow proxy decreased 182.7%
Free-cash-flow proxy changed -182.7% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Free-cash-flow proxy changed -182.7% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Operating income changed -185.7% from the comparable as-filed period.
Operating cash flow changed -195.3% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Operating margin changed +33128 basis points from the comparable as-filed period.
Current liabilities changed +918.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a low base.
Revenue changed +327.5% from the comparable as-filed period.
Gross margin changed -1885 basis points from the comparable as-filed period.
Research & development changed +675.5% from the comparable as-filed period.
Cash & equivalents changed +224.4% from the comparable as-filed period.
Inventory / revenue changed -5745 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Shares outstanding changed +66.8% from the comparable as-filed period. The change ranks at the 62th percentile of 8 prior comparable changes.
Capex / revenue changed -7023 basis points from the comparable as-filed period.
Current assets changed +167.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Gross profit changed +158.7% from the comparable as-filed period.
Total assets changed +320.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Working capital changed +113.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
SBC / revenue changed -28099 basis points from the comparable as-filed period.
Capital expenditure changed +127.4% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Inventory changed +46.0% from the comparable as-filed period.
R&D / revenue changed +5977 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Free-cash-flow margin changed +27410 basis points from the comparable as-filed period.
Operating cash-flow margin changed +20388 basis points from the comparable as-filed period.
Current ratio changed -73.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Working capital / assets changed -3437 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Stock-based compensation changed +2.5% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.